LifeCell develops and markets tissue repair products for use in reconstructive, urogynecologic and orthopedic surgical procedures.  LifeCell's leading technologies include: Strattice™, for reconstructive and general surgical procedures; and AlloDerm®, for plastic reconstructive, general surgical, burn and periodontal procedures and Cymetra®, a particle form of AlloDerm suitable for injection. 
 
LifeCell’s patented tissue matrix was developed in 1994 as a graft for burn patients.  Since then, AlloDerm’s versatility has led to its use in many other reconstructive applications, allowing surgeons to restore tissue damaged through injury or disease - using the regenerative power of the patients’ own tissues.

Our mission today is the same as it was when we began almost twenty years ago: to improve quality of life for those most in need of our help. It takes committed, caring people to achieve that vision—people with the expertise, creativity and dedication to bring new innovations to life.  Maybe someone like you.

Accounting/Finance/Insurance, Administrative/Clerical, Biotech/R&D/Science (14 more)